China New Product Influenza A Virus, Influenza B Virus, Adenovirus, Mycoplasma Pneumoniae - Macro & Micro-Test Sample Release Reagent – Macro & Micro-Test
China New Product Influenza A Virus, Influenza B Virus, Adenovirus, Mycoplasma Pneumoniae - Macro & Micro-Test Sample Release Reagent – Macro & Micro-Test Detail:
Product name
Macro & Micro-Test Sample Release Reagent
Certificate
CE, FDA, NMPA
Features
Rapid: only 5 mins.
Easy: only 3 steps (1.add the sample 2.Mix upside and down 10 times 3. Leave it for 5 mins).
Main components
| Name | Main components | Component specifications | Quantity |
| Sample Release reagent | Dithiothreitol, sodium dodecyl sulfate (SDS), RNase inhibitor, surfactant, purified water | 0.5mL/Vial | 50 Vial |
Note: Components in different batches of kits are not interchangeable.
Storage conditions and shelf life
Store and transport at room temperature. The shelf life is 24 months.
Applicable instruments
Instruments and equipment during sample processing, such as pipettes, vortex mixers, water baths, etc.
Sample requirements
Freshly collected oropharyngeal swabs, nasopharyngeal swabs.
Precision
When this kit is used for extraction from the in-house precision reference CV for 10 replicates, the coefficient of variation (CV, %) of Ct value is not more than 10%.
Inter-batch difference
When the in-house precision reference is tested on three batches of kits under trial production upon repeated extraction and, the coefficient of variation (CV, %) of Ct value is not more than 10%.
Performance comparison
● Extraction efficiency comparsion
|
Efficiency comparsion of magnetic beads method and sample releaser |
||||
|
concentration |
magnetic beads method |
sample releaser |
||
|
orfab |
N |
orfab |
N |
|
|
20000 |
28.01 |
28.76 |
28.6 |
29.15 |
|
2000 |
31.53 |
31.9 |
32.35 |
32.37 |
|
500 |
33.8 |
34 |
35.25 |
35.9 |
|
200 |
35.25 |
35.9 |
35.83 |
35.96 |
|
100 |
36.99 |
37.7 |
38.13 |
undet |
The extraction efficiency of sample releaser was similar to that of magnetic beads method, and the concentration of pathogen could be 200Copies/mL.
● CV value comparison
|
Repeatability of sample releaser extraction |
||
| concentration:5000Copies/mL |
ORF1ab |
N |
|
30.17 |
30.38 |
|
|
30.09 |
30.36 |
|
|
30.36 |
30.26 |
|
|
30.03 |
30.48 |
|
|
30.14 |
30.45 |
|
|
30.31 |
30.16 |
|
|
30.38 |
30.7 |
|
|
30.72 |
30.79 |
|
| CV |
0.73% |
0.69% |
When tested at 5,000 copies /mL, the CV of orFab and N was 0.73% and 0.69%, respectively.
Product detail pictures:
Related Product Guide:
In the past few years, our business absorbed and digested advanced technologies both equally at home and abroad. In the meantime, our company staffs a group of experts devoted to your advancement of China New Product Influenza A Virus, Influenza B Virus, Adenovirus, Mycoplasma Pneumoniae - Macro & Micro-Test Sample Release Reagent – Macro & Micro-Test , The product will supply to all over the world, such as: Southampton, Zambia, Brunei, For more than ten years experience in this filed, our company has gained high reputation from home and abroad. So we welcome friends from all over the world to come and contact us, not only for business, but also for friendship.
By Meredith from Turkey - 2018.12.22 12:52
This manufacturers not only respected our choice and requirements, but also gave us a lot of good suggestions, ultimately， we successfully completed the procurement tasks.
By Elsie from Serbia - 2017.08.21 14:13
